Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Fenoglio

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|August 27, 2021
COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease TrialChiara Agrati, Serena Di Cosimo, Daniela Fenoglio, et al.
Blood|October 27, 2005
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancerGilberto Filaci, Marco Fravega, Maurizio Setti, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|October 3, 2020
CD38 downregulation modulates NAD<sup>+</sup> and NADP(H) levels in thermogenic adipose tissuesAndrea Benzi, Laura Sturla, Markus Heine, et al.
Medicine 2.0|July 31, 2014
The ligurian human immunodeficiency virus clinical network: a web tool to manage patients with human immunodeficiency virus in primary care and multicenter clinical trialsPaolo Fraccaro, Valeria Pupella, Roberta Gazzarata, et al.
Clinical and Experimental Medicine|November 14, 2022
Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunctionChiara Dentone, Daniela Fenoglio, Alessia Parodi, et al.
The Journal of Allergy and Clinical Immunology|February 2, 2025
BNT162b2 COVID-19 vaccination elicits the expansion of CD16<sup>+</sup>CD8<sup>+</sup> T cells endowed with natural killer cell featuresClaudia De Pasquale, Fabiana Drommi, Alessia Calabrò, et al.
Cancer Treatment Reviews|September 29, 2024
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancerFederico Rebaudi, Fabiana De Franco, Rayan Goda, et al.
European Journal of Immunology|July 25, 2020
Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patientsFrancesca Schena, Federica Penco, Stefano Volpi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancersGilberto Filaci, Daniela Fenoglio, Marco Fravega, et al.
Frontiers in Immunology|April 28, 2022
Case Report: Atypical Manifestations Associated With FOXP3 Mutations. The "Fil Rouge" of Treg Between IPEX Features and Other Clinical Entities?Micaela Gentile, Maurizio Miano, Paola Terranova, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|August 27, 2021
COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease TrialChiara Agrati, Serena Di Cosimo, Daniela Fenoglio, et al.
Blood|October 27, 2005
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancerGilberto Filaci, Marco Fravega, Maurizio Setti, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|October 3, 2020
CD38 downregulation modulates NAD<sup>+</sup> and NADP(H) levels in thermogenic adipose tissuesAndrea Benzi, Laura Sturla, Markus Heine, et al.
Medicine 2.0|July 31, 2014
The ligurian human immunodeficiency virus clinical network: a web tool to manage patients with human immunodeficiency virus in primary care and multicenter clinical trialsPaolo Fraccaro, Valeria Pupella, Roberta Gazzarata, et al.
Clinical and Experimental Medicine|November 14, 2022
Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunctionChiara Dentone, Daniela Fenoglio, Alessia Parodi, et al.
The Journal of Allergy and Clinical Immunology|February 2, 2025
BNT162b2 COVID-19 vaccination elicits the expansion of CD16<sup>+</sup>CD8<sup>+</sup> T cells endowed with natural killer cell featuresClaudia De Pasquale, Fabiana Drommi, Alessia Calabrò, et al.
Cancer Treatment Reviews|September 29, 2024
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancerFederico Rebaudi, Fabiana De Franco, Rayan Goda, et al.
European Journal of Immunology|July 25, 2020
Dysregulation in B-cell responses and T follicular helper cell function in ADA2 deficiency patientsFrancesca Schena, Federica Penco, Stefano Volpi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2007
CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancersGilberto Filaci, Daniela Fenoglio, Marco Fravega, et al.
Frontiers in Immunology|April 28, 2022
Case Report: Atypical Manifestations Associated With FOXP3 Mutations. The "Fil Rouge" of Treg Between IPEX Features and Other Clinical Entities?Micaela Gentile, Maurizio Miano, Paola Terranova, et al.
Pageof 11